Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D C Ross

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Plos One|November 16, 2019
Acceptability of and treatment preferences for recurrent bacterial vaginosis-Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trialJocelyn Anstey Watkins, Jonathan D C Ross, Sukhwinder Thandi, et al.
International Journal of STD & AIDS|December 20, 2013
2013 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogensHenry J C de Vries, Adele Zingoni, John A White, et al.
British Journal of Clinical Pharmacology|September 24, 2017
Adverse effects of a single dose of gentamicin in adults: a systematic reviewRachel S Hayward, Jan Harding, Rob Molloy, et al.
The Lancet Regional Health. Europe|November 6, 2023
Treatment of bacterial sexually transmitted infections in Europe: gonorrhoea, <i>Mycoplasma genitalium</i>, and syphilisOriol Mitjà, Clara Suñer, Lorenzo Giacani, et al.
Trials|November 25, 2016
Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trialClare Brittain, Margaret Childs, Lelia Duley, et al.
International Journal of STD & AIDS|March 8, 2024
British association for sexual health and HIV national guideline for the management of anogenital warts in adults (2024)Diarmuid Nugent, Ade Apoola, Harry Coleman, et al.
Trials|November 29, 2019
Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosisLindsay Armstrong-Buisseret, Clare Brittain, Miruna David, et al.
Sexually Transmitted Infections|August 25, 2025
What guidance exists to support remote consultations in sexual and reproductive health services? A review of the policy and practice literatureCharlotte Spurway, Iestyn Williams, Christian Bohm, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2019
Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcomeMichelle J Cole, Wei Tan, Helen Fifer, et al.
Mbio|January 30, 2026
Inhibition of <i>Neisseria gonorrhoeae</i> complement-mediated killing during acute gonorrhea is dependent upon the IgG2:IgG3 antibody ratioSamantha A McKeand, Sian E Faustini, Alex Cook, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Plos One|November 16, 2019
Acceptability of and treatment preferences for recurrent bacterial vaginosis-Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trialJocelyn Anstey Watkins, Jonathan D C Ross, Sukhwinder Thandi, et al.
International Journal of STD & AIDS|December 20, 2013
2013 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogensHenry J C de Vries, Adele Zingoni, John A White, et al.
British Journal of Clinical Pharmacology|September 24, 2017
Adverse effects of a single dose of gentamicin in adults: a systematic reviewRachel S Hayward, Jan Harding, Rob Molloy, et al.
The Lancet Regional Health. Europe|November 6, 2023
Treatment of bacterial sexually transmitted infections in Europe: gonorrhoea, <i>Mycoplasma genitalium</i>, and syphilisOriol Mitjà, Clara Suñer, Lorenzo Giacani, et al.
Trials|November 25, 2016
Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trialClare Brittain, Margaret Childs, Lelia Duley, et al.
International Journal of STD & AIDS|March 8, 2024
British association for sexual health and HIV national guideline for the management of anogenital warts in adults (2024)Diarmuid Nugent, Ade Apoola, Harry Coleman, et al.
Trials|November 29, 2019
Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosisLindsay Armstrong-Buisseret, Clare Brittain, Miruna David, et al.
Sexually Transmitted Infections|August 25, 2025
What guidance exists to support remote consultations in sexual and reproductive health services? A review of the policy and practice literatureCharlotte Spurway, Iestyn Williams, Christian Bohm, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2019
Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcomeMichelle J Cole, Wei Tan, Helen Fifer, et al.
Mbio|January 30, 2026
Inhibition of <i>Neisseria gonorrhoeae</i> complement-mediated killing during acute gonorrhea is dependent upon the IgG2:IgG3 antibody ratioSamantha A McKeand, Sian E Faustini, Alex Cook, et al.
Pageof 6